BCAX
Bicara Therapeutics Inc.
19.20$
-2.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | – | – | – | |
| – | +90.0% | +194.7% | +625.0% | |
| – | +134.4% | +289.5% | +102.9% | |
| – | -294.5% | – | – | |
| – | +205.2% | -87.9% | +294.4% | |
| – | +205.2% | -98.5% | +3,538,266.7% | |
| – | +759.7% | +22.6% | -90.3% | |
| – | – | +14.6% | -251.6% | |
| – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.